BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 29743654)

  • 1. Expression of the transcription factor ZBTB46 distinguishes human histiocytic disorders of classical dendritic cell origin.
    Satpathy AT; Brown RA; Gomulia E; Briseño CG; Mumbach MR; Pan Z; Murphy KM; Natkunam Y; Chang HY; Kim J
    Mod Pathol; 2018 Sep; 31(9):1479-1486. PubMed ID: 29743654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages.
    Satpathy AT; KC W; Albring JC; Edelson BT; Kretzer NM; Bhattacharya D; Murphy TL; Murphy KM
    J Exp Med; 2012 Jun; 209(6):1135-52. PubMed ID: 22615127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological consequence of misguided dendritic cell differentiation in histiocytic diseases.
    Berres ML; Allen CE; Merad M
    Adv Immunol; 2013; 120():127-61. PubMed ID: 24070383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent detection of BRAF(V600E) mutations in histiocytic and dendritic cell neoplasms.
    Go H; Jeon YK; Huh J; Choi SJ; Choi YD; Cha HJ; Kim HJ; Park G; Min S; Kim JE
    Histopathology; 2014 Aug; 65(2):261-72. PubMed ID: 24720374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant Histiocytosis Comprises a Phenotypic Spectrum That Parallels the Lineage Differentiation of Monocytes, Macrophages, Dendritic Cells, and Langerhans Cells.
    Ravindran A; Dasari S; Ruan GJ; Artymiuk CJ; He R; Viswanatha DS; Abeykoon JP; Zanwar S; Young JR; Goyal G; Go RS; Rech KL;
    Mod Pathol; 2023 Oct; 36(10):100268. PubMed ID: 37406859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation.
    Kemps PG; Hebeda KM; Pals ST; Verdijk RM; Lam KH; Bruggink AH; de Lil HS; Ruiterkamp B; de Heer K; van Laar JA; Valk PJ; Mutsaers P; Levin MD; Hogendoorn PC; van Halteren AG
    J Pathol Clin Res; 2021 Jan; 7(1):10-26. PubMed ID: 32852896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histiocytic and Dendritic Cell Neoplasms.
    Pan Z; Xu ML
    Surg Pathol Clin; 2019 Sep; 12(3):805-829. PubMed ID: 31352989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Histiocytic diseases in childhood and adolescence].
    Vokuhl C; Oschlies I; Klapper W; Leuschner I
    Pathologe; 2015 Sep; 36(5):443-50. PubMed ID: 26292932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phosphatidylserine receptors, T cell immunoglobulin mucin proteins 3 and 4, are markers of histiocytic sarcoma and other histiocytic and dendritic cell neoplasms.
    Dorfman DM; Hornick JL; Shahsafaei A; Freeman GJ
    Hum Pathol; 2010 Oct; 41(10):1486-94. PubMed ID: 20656318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Descriptive Analysis of Histiocytic and Dendritic Cell Neoplasms: A Single-Institution Experience.
    Kim HM; Yang WI; Lyu CJ; Hahn SM; Yoon SO
    Yonsei Med J; 2020 Sep; 61(9):774-779. PubMed ID: 32882761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases.
    Facchetti F; Pileri SA; Lorenzi L; Tabanelli V; Rimsza L; Pittaluga S; Dirnhofer S; Copie-Bergman C; de Leval L; Rosenwald A; Wotherspoon A; Fend F
    Virchows Arch; 2017 Oct; 471(4):467-489. PubMed ID: 28695297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders.
    Lau SK; Chu PG; Weiss LM
    Am J Surg Pathol; 2008 Apr; 32(4):615-9. PubMed ID: 18277880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solitary and generalized variants of spindle cell xanthogranuloma (progressive nodular histiocytosis).
    Zelger BW; Staudacher C; Orchard G; Wilson-Jones E; Burgdorf WH
    Histopathology; 1995 Jul; 27(1):11-9. PubMed ID: 7557901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The histiocytoses: clinical presentation and differential diagnosis.
    Gonzalez CL; Jaffe ES
    Oncology (Williston Park); 1990 Nov; 4(11):47-60; discussion 60, 62. PubMed ID: 2150325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demographics and additional haematologic cancers of patients with histiocytic/dendritic cell neoplasms.
    Kemps PG; Kester L; Scheijde-Vermeulen MA; van Noesel CJM; Verdijk RM; Diepstra A; van Marion AMW; Dors N; van den Bos C; Bruggink AH; Hogendoorn PCW; van Halteren AGS
    Histopathology; 2024 Apr; 84(5):837-846. PubMed ID: 38213281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histiocytic disorders of the gastrointestinal tract.
    Detlefsen S; Fagerberg CR; Ousager LB; Lindebjerg J; Marcussen N; Nathan T; Sørensen FB
    Hum Pathol; 2013 May; 44(5):683-96. PubMed ID: 23063502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histiocytosis and Neoplasms of Macrophage-Dendritic Cell Lineages: Multimodality Imaging with Emphasis on PET/CT.
    Huynh KN; Nguyen BD
    Radiographics; 2021; 41(2):576-594. PubMed ID: 33606566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma.
    Massoth LR; Hung YP; Ferry JA; Hasserjian RP; Nardi V; Nielsen GP; Sadigh S; Venkataraman V; Selig M; Friedmann AM; Samore W; Killian JK; Milante R; Giessinger J; Foley-Peres K; Marcus C; Severson E; Duncan D; Sivakumar S; Ross JS; Desphande V; Ramkissoon SH; Vergilio JA; Louissaint A; Zukerberg LR; Williams EA
    Oncologist; 2021 Jul; 26(7):e1263-e1272. PubMed ID: 33904632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cladribine is highly effective in the treatment of Langerhans cell histiocytosis and rare histiocytic disorders of the juvenile xanthogranuloma group].
    Adam Z; Szturz P; Pour L; Krejčí M; Zahradová L; Tomíška M; Král Z; Koukalová R; Rehák Z; Mayer J
    Vnitr Lek; 2012 Jun; 58(6):455-65. PubMed ID: 22913238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1.
    Gatalica Z; Bilalovic N; Palazzo JP; Bender RP; Swensen J; Millis SZ; Vranic S; Von Hoff D; Arceci RJ
    Oncotarget; 2015 Aug; 6(23):19819-25. PubMed ID: 26110571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.